首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Nivolumab/pembrolizumabPneumonia: case report
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2021年
/ 1846卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-021-92491-2
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:243 / 243
相关论文
共 50 条
[41]
Nivolumab/pazopanibHepatitis and neuropathy: case report
Reactions Weekly,
2020,
1796
(1)
: 189
-
189
[42]
Nivolumab/TozinameranSweet syndrome: case report
Reactions Weekly,
2025,
2045
(1)
: 330
-
330
[43]
Nivolumab/pazopanibHepatotoxicity and fatigue: case report
Reactions Weekly,
2019,
1777
(1)
: 183
-
183
[44]
Nivolumab/prednisoneVarious toxicities: case report
Reactions Weekly,
2021,
1861
(1)
: 256
-
256
[45]
Nivolumab/temsirolimusVarious toxicities: case report
Reactions Weekly,
2022,
1919
(1)
: 460
-
460
[46]
Nivolumab/pazopanibVarious toxicities: case report
Reactions Weekly,
2022,
1887
(1)
: 533
-
533
[47]
Nivolumab/omeprazoleLack of efficacy: case report
Reactions Weekly,
2025,
2056
(1)
: 430
-
430
[48]
Nivolumab/pazopanibLack of efficacy: case report
Reactions Weekly,
2022,
1898
(1)
: 311
-
311
[49]
Nivolumab/sunitinibVarious toxicities: case report
Reactions Weekly,
2022,
1905
(1)
: 402
-
402
[50]
Nivolumab/oxaliplatinVarious toxicities : case report
Reactions Weekly,
2024,
2017
(1)
: 393
-
393
←
1
2
3
4
5
→